|
TGF-β Signaling in Development (Supplemental Table)
Krit Kitisin,1 Tapas Saha,1 Tiffany Blake,1 Nady Golestaneh,1 Merlyn Deng,1 Christine Kim,1 Yi Tang,1 Kirti Shetty,1 Bibhuti Mishra,1 Lopa Mishra1,2*
1Laboratory of Cancer Genetics and Digestive Diseases, Departments of Surgery, Medicine, and LCCC, Georgetown University, Washington, DC 20007, USA. 2DVAMC, Washington, DC 20007, USA.
Supplemental Table. TGF-β signaling in development based on mouse knockout and mutant analysis.
|
| Developmental stage or process |
Ligands |
Receptors |
Intracellular signaling molecules |
Citations |
|
| Primitive streak formation |
Nodal |
ALK2, ActRII, ActRIIB |
Smad2, Smad4 |
1 |
|
| Mesoderm formation |
BMP2, BMP4, Nodal |
ALK2, ALK3, ALK4 |
Smad2, Smad4 |
1, 2 |
|
| Endoderm formation |
Cripto, Nodal, BMP4 |
ALK2, ActRI |
Smad4 |
3, 2, 4 |
|
| Cardiac development |
BMP2, Cripto, Endoglin |
ActRIIB, ALK2 |
Smad4, Smad5, Smad6 |
5, 6 |
|
| Kidney development |
BMP7, BMP2, BMP4 |
ALK4, BMPRII, BMPRIA, BMPRIB |
Smad1, Smad4, Smad5, Smad8 |
7 |
|
| Bone development |
TGF-β2, TGF-β3, BMP4 |
ALK6, ActRIIA |
Smad1, Smad5, Smad8 |
1 |
|
| Liver and gastrointestinal tract development |
BMP1, BMP4, BMP7 |
BMPR1A, ActRII, ActRIIB |
Smad2, Smad3, ELF, Smad4 |
7, 8 |
|
| Vasculogenesis and hematopoesis |
TGF-β1 |
TβRI, TβRII |
Smad5 |
9, 10, 11 |
|
E-mail, lopamishra{at}yahoo.com
References
- M. J. Goumans, C.
Mummery, Functional analysis of the TGFβ receptor/Smad pathway
through gene ablation in mice. Int. J. Dev. Biol.
44, 253–265 (2000).
-
C. Sirard, J. L. de la Pompa, A. Elia, A. Itie, C.
Mirtsos, A. Cheung, S. Hahn, A. Wakeham, L. Schwartz, S. E.
Kern, J. Rossant, T. W. Mak, The tumor suppressor gene
Smad4/Dpc4 is required for gastrulation and later for anterior
development of the mouse embryo. Genes Dev.
12, 107–119 (1998).
-
R. Derynck, Y. E. Zhang, Smad-dependent and
Smad-independent pathways in TGF-β family signalling.
Nature 425, 577–584 (2003).
- L. Strizzi, C. Bianco, N. Normanno, D. Salomon,
Cripto-1: A multifunctional modulator during embryogenesis and
oncogenesis. Oncogene 24, 5731–5741 (2005).
-
J. S. Desgrosellier, N. A. Mundell, M. A. McDonnell,
H. L. Moses, J. V. Barnett, Activin receptor-like kinase 2 and
Smad6 regulate epithelial-mesenchymal transformation during
cardiac valve formation. Dev. Biol. 280,
201–210 (2005).
-
H. Zhang, A. Bradley, Mice deficient for BMP2 are
nonviable and have defects in amnion/chorion and cardiac
development. Development 122, 2977–2986
(1996).
- J. Massague, S. W. Blain, R. S. Lo, TGFβ signaling in
growth control, cancer, and heritable disorders. Cell
103, 295–309 (2000).
-
Y. Tang, V. Katuri, A. Dillner, B. Mishra, C. X. Deng,
L. Mishra, Disruption of transforming growth factor-β
signaling in ELF β-spectrin-deficient mice.
Science 299, 574–577 (2003).
-
J. Larsson, M. J. Goumans, L. J. Sjostrand, M. A. van
Rooijen, D. Ward, P. Leveen, X. Xu, P. ten Dijke, C. L.
Mummery, S. Karlsson, Abnormal angiogenesis but intact
hematopoietic potential in TGF-β type I
receptor-deficient mice. EMBO J. 20, 1663–1673
(2001).
-
M. Oshima, H. Oshima, M. M. Taketo, TGF-β
receptor type II deficiency results in defects of yolk sac
hematopoiesis and vasculogenesis. Dev. Biol.
179, 297–302 (1996).
-
B. Liu, Y. Sun, F. Jiang, S. Zhang, Y. Wu, Y. Lan, X.
Yang, N. Mao, Disruption of Smad5 gene leads to enhanced
proliferation of high-proliferative potential precursors
during embryonic hematopoiesis. Blood 101,
124–133 (2003).
Citation: K. Kitisin, T. Saha, T. Blake, N. Golestaneh, M.
Deng, C. Kim, Y. Tang, K. Shetty, B. Mishra, L. Mishra, TGF-β
signaling in development. Sci. STKE (Connections Map in
Database of Cell Signaling, as seen July 2007)
http://stke.sciencemag.org/cgi/cm/stkecm;CMP_18196.
|
|